Geodon, Ziprasidone Newswire

Geodon, Ziprasidone Newswire

Comprehensive Real-Time News Feed for Geodon, Ziprasidone (generic).

Results 1 - 20 of 35 in Geodon, Ziprasidone (generic)

  1. Antipsychotic Meds Pose Little Danger to Fetus, Study FindsRead the original story w/Photo

    Wednesday Aug 17 | HON

    "In general, the use of any medication should be avoided during pregnancy [if possible]," explained study co-author Krista Huybrechts of Brigham and Women's Hospital in Boston. "However, for women suffering from schizophrenia, bipolar disorder, or major depressive disorder, avoiding medication use is often impossible, given that there are very few alternative treatment options," she said in a hospital news release.

    Comment?

  2. Antipsychotic meds pose little danger to fetus, study findsRead the original story w/Photo

    Wednesday Aug 17 | UPI

    "In general, the use of any medication should be avoided during pregnancy [if possible]," explained study co-author Krista Huybrechts of Brigham and Women's Hospital in Boston. "However, for women suffering from schizophrenia, bipolar disorder, or major depressive disorder, avoiding medication use is often impossible, given that there are very few alternative treatment options," she said in a hospital news release.

    Comment?

  3. Study examines use of antipsychotics early in pregnancy, risk of birth defectsRead the original story w/Photo

    Wednesday Aug 17 | PhysOrg Weblog

    A study of 1.3 million pregnant women suggests antipsychotic medication early in pregnancy was not associated with a meaningful increase in the risk of birth defects when other mitigating factors were considered, although the medication risperidone needs further research, according to a study published online by JAMA Psychiatry .

    Comment?

  4. Antipsychotic medication poses little risk to developing fetusRead the original story w/Photo

    Tuesday Aug 16 | EurekAlert!

    Exposure to antipsychotic medications during pregnancy is increasingly common. Widespread use of newer "atypical" drugs which are less likely to affect fertility than the older "typical" antipsychotics, combined with the deinstitutionalization of psychiatric patients, is attributed to doubling the use of antipsychotics during pregnancy in the past decade, yet, clinicians have little information regarding the safety of these drugs for the developing fetus and concerns have been raised about a potential association with congenital malformations.

    Comment?

  5. Ziprasidone Industry 2016 Analysis and 2021 Forecasts for Global and Chinese MarketsRead the original story

    Wednesday Aug 17 | Emailwire.com

    Reportsweb.com adds "Global Ziprasidone Industry 2016 Market Research Report" to its store. The report introduced Molten Carbonate fuel Cell market shares, new investment project, SWOT analysis and development trends.

    Comment?

  6. Weight gain studied for second-generation antipsychotics for autism spectrum disordersRead the original story w/Photo

    Jul 18, 2016 | PhysOrg Weblog

    Some of the most effective treatments for autism spectrum disorder are also well known for their risk of weight gain and subsequent health complications. For the first time, however, researchers have compared five of these second generation antipsychotics to determine which ones are the biggest culprits.

    Comment?

  7. Weight gain studied for second-generation antipsychotics for autism spectrum disordersRead the original story w/Photo

    Jul 17, 2016 | EurekAlert!

    Some of the most effective treatments for autism spectrum disorder are also well known for their risk of weight gain and subsequent health complications. For the first time, however, researchers have compared five of these second generation antipsychotics to determine which ones are the biggest culprits.

    Comment?

  8. Schizophrenia Treatment Market Regulations and Competitive Landscape Outlook to 2026Read the original story w/Photo

    Jul 14, 2016 | SBWire

    Schizophrenia is a chronic mental disorder, characterized by poor emotional responses, breakdown of thinking and lack of social and physical motivation. The prominent causes of the disease include genetic malignancies, neuro-trauma, shocking incidence in life, drug and alcohol abuse and many others.

    Comment?

  9. Antipsychotics and amotivation.Read the original story

    Jun 28, 2016 | CiteULike

    Antipsychotic drugs are thought to produce secondary negative symptoms, which can also exacerbate primary negative symptoms. In the present study, we examined whether motivational deficits in particular were related to antipsychotic treatment in patients with schizophrenia in a dose-dependent manner.

    Comment?

  10. Drug Shills Dispensing PillsRead the original story w/Photo

    Jun 23, 2016 | Psychology Today

    Source: By PA llA [CC BY 3.0 ], via Wikimedia Commons In 2009, as an eager young psychiatry professor at New York-Presbyterian Hospital, I presented to faculty on the need for a moral dimension to psychiatric diagnoses. I was laughed out of the room.

    Comment?

  11. FMI Releases New Report on the Global Schizophrenia Treatment MarketRead the original story w/Photo

    May 26, 2016 | SBWire

    Schizophrenia is a chronic mental disorder, characterized by poor emotional responses, breakdown of thinking and lack of social and physical motivation. The prominent causes of the disease include genetic malignancies, neuro-trauma, shocking incidence in life, drug and alcohol abuse and many others.

    Comment?

  12. Major Depressive Disorder (MDD) Treatment Market Segments and Key Trends 2016-2026Read the original story w/Photo

    May 26, 2016 | SBWire

    Major Depressive Disorder is one of the most common mental disorder characterized by persistent and tenacious low mood that interferes with the person's ability to work, eat, sleep and normal activities. MDD is also referred as clinical depression, major depression, and unipolar depression or as recurrent depression.

    Comment?

  13. Dealing with schizophrenia poses significant challengesRead the original story

    May 14, 2016 | Altoona Mirror

    It is a disorder that involves psychosis - a loss of contact with reality - in which symptoms like hallucinations and delusions markedly distort perception. People with hallucinations see and/or hear things that are not real.

    Comment?

  14. Are Drug Prices Really Too High?Read the original story w/Photo

    May 5, 2016 | JD Supra

    Those working in the pharmaceutical space are used to hearing complaints about the high costs of drugs, and patents often are blamed for allowing pharmaceutical companies to charge "too much" for their products. But are drug prices really too high when you consider the alternatives? Concerns over drug prices are not new, but drug pricing has gotten more attention as new drugs seem to come with higher and higher price tags.

    Comment?

  15. Global Psychotherapeutic Drugs Market to Be Driven by Growing Demand for Antipsychotic DrugsRead the original story w/Photo

    May 4, 2016 | SBWire

    A new market research report by Transparency Market Research on the global psychotherapeutic drugs market offers a detailed overview of the market and points out the key drivers and restraints impacting the growth of the market. The report, titled "Psychotherapeutic Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," projects the valuation and size of the global psychotherapeutic drugs market during the period between 2013 and 2019.

    Comment?

  16. Major Depressive Disorder (MDD) Treatment Market Segments,...Read the original story w/Photo

    Apr 15, 2016 | SBWire

    Major Depressive Disorder is one of the most common mental disorder characterized by persistent and tenacious low mood that interferes with the person's ability to work, eat, sleep and normal activities. MDD is also referred as clinical depression, major depression, and unipolar depression or as recurrent depression.

    Comment?

  17. Global and China Ziprasidone Mesylate Market 2016: Analysis, Growth, Share, Demand & Forecast to 2021Read the original story w/Photo

    Mar 4, 2016 | SBWire

    Global and China Ziprasidone Mesylate Market 2016-2021 Market Research Report Complete report With TOC available: The report on the Global and China Ziprasidone Mesylate Market 2016 Industry meticulously addresses the various drivers, restraints, and opportunities that exist in this space. Compiled by a team of expert analysts, the report offers an overview of the all the key performance indicators of the Global and China Ziprasidone Mesylate Market 2016 Industry.The study analyzes the Global and China Ziprasidone Mesylate Market 2016 Industry in terms of revenue and volume, where applicable.

    Comment?

  18. IntelGenx Files Loxapine Oral Film Patent for SchizophreniaRead the original story w/Photo

    Feb 10, 2016 | Market Wire

    IntelGenx Corp., , today announced that it has submitted a patent application with the US patent office for an oral film dosage form containing Loxapine for the treatment of anxiety and aggression in patients suffering from schizophrenia or bipolar 1 disorder. The product utilizes the company's proprietary VersaFilm technology, allowing for an improved product to offer patients significant therapeutic benefits compared to existing medications.

    Comment?

  19. Schizophrenia Therapeutic Market (2015 to 2021) - Global Market Study and AnalysisRead the original story w/Photo

    Jan 21, 2016 | SBWire

    North America dominates the global market for schizophrenia therapeutics due to increasing mental disorders. Asia is expected to show high growth rates in the next five years in the global schizophrenia therapeutics market.

    Comment?

  20. The Introduction of Generic Risperidone in Medicare Part DRead the original story

    Jan 20, 2016 | The American Journal of Managed Care

    This study examines the plan characteristics associated with generic risperidone use and spending and adherence outcomes associated with use among Medicare Advantage Part D beneficiaries. Vicki Fung, PhD; Mary Price, MA; Alisa B. Busch, MD, MS; Mary Beth Landrum, PhD; Bruce Fireman, MA; Andrew A. Nierenberg, MD; Joseph P. Newhouse, PhD; and John Hsu, MD, MBA, MSCE ABSTRACT Objectives: The introduction of generic second-generation antipsychotics , starting with risperidone in July 2008, could reduce antipsychotic spending and cost-related use barriers.

    Comment?